At the time of writing, Edwards Lifesciences Corp [EW] stock is trading at $72.56, up 4.86%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The EW shares have gain 3.70% over the last week, with a monthly amount drifted -3.74%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Edwards Lifesciences Corp [NYSE: EW] stock has seen the most recent analyst activity on January 16, 2025, when Wolfe Research downgraded its rating to a Underperform but kept the price target unchanged to $60 for it. Previously, BofA Securities upgraded its rating to Buy on December 16, 2024. Jefferies downgraded its rating to a Hold and decreased its price target to $70 on September 18, 2024. Daiwa Securities upgraded its rating to a Outperform. Wolfe Research upgraded its rating to Peer Perform for this stock on July 29, 2024. In a note dated July 25, 2024, Truist downgraded an Hold rating on this stock and revised its target price from $110 to $82.
For the past year, the stock price of Edwards Lifesciences Corp fluctuated between $58.93 and $96.12. Currently, Wall Street analysts expect the stock to reach $75.08 within the next 12 months. Edwards Lifesciences Corp [NYSE: EW] shares were valued at $72.56 at the most recent close of the market. An investor can expect a potential return of 3.47% based on the average EW price forecast.
Analyzing the EW fundamentals
According to Edwards Lifesciences Corp [NYSE:EW], the company’s sales were 5.87B for trailing twelve months, which represents an -8.54% plunge. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.27%, Pretax Profit Margin comes in at 0.28%, and Net Profit Margin reading is 0.71%. To continue investigating profitability, this company’s Return on Assets is posted at 0.32, Equity is 0.54 and Total Capital is 0.14. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 70.13 points at the first support level, and at 67.69 for the second support level. However, for the 1st resistance point, the stock is sitting at 73.87, and for the 2nd resistance point, it is at 75.17.
Ratios To Look Out For
It is important to note that Edwards Lifesciences Corp [NYSE:EW] has a current ratio of 3.46. As well, the Quick Ratio is 2.89, while the Cash Ratio is 1.89. Considering the valuation of this stock, the price to sales ratio is 7.29, the price to book ratio is 4.48 and price to earnings (TTM) ratio is 10.47.
Transactions by insiders
Recent insider trading involved Lippis Daniel J., CVP, JAPAC, that happened on Jan 16 ’25 when 500.0 shares were sold. CVP,Strategy/Corp Development, BOBO DONALD E JR completed a deal on Jan 16 ’25 to sell 5000.0 shares. Meanwhile, Officer Lippis Daniel J. bought 500.0 shares on Jan 16 ’25.
